A retrospective poison center review of varenicline-exposed patients

Annals of Pharmacotherapy

Volumn 43, Issue 12, 2009, Pages 1986-1991

  Kreshak, Allyson A ^a   Clark, Alycia K ^b   Clark, Richard F ^a   Ly, Binh T ^c   Cantrell, F Lee ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b California Poison Control System San Diego Division   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Nicotine; Poison center; Smoking cessation; Varenicline

Indexed keywords

ACTIVATED CARBON; VARENICLINE;

ADOLESCENT; ADULT; AGITATION; ARTICLE; ATAXIA; CHILD; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DATA BASE; DOSE RESPONSE; DRUG INTOXICATION; EMERGENCY HEALTH SERVICE; EXPOSURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE FACILITY; HOME; HOSPITAL ADMISSION; HUMAN; MALE; MEDICATION ERROR; MIOSIS; NAUSEA; NEUROLOGIC DISEASE; POISON CENTER; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; UNITED STATES;

ADOLESCENT; ADULT; BENZAZEPINES; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; INFANT; MALE; MEDICATION ERRORS; MENTAL DISORDERS; NICOTINIC AGONISTS; POISON CONTROL CENTERS; QUINOXALINES; RETROSPECTIVE STUDIES; SMOKING CESSATION;

EID: 72249122934     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M454     Document Type: Article

References (16)

1. McColl SL, Burnstein AH, Reeves KR, et al. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. Clin Pharmacol Ther 2008;83:607-614
2. 4 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation. JAMA 2006;296:56-63.
3. 4 nicotinic receptor partial agonist. Arch Intern Med 2006;166:1561-1568
4. 4 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. JAMA 2006;296:47-55.
5. Oncken C, Gonzales D, Nides M, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 2006;166:1571-1577 (Pubitemid 44232364)
6. 4 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers. Clin Ther 2007;29:1027-1039
7. 4 acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther 2007;29:1040-1056
8. Product information. Chantix (varenicline). www.Pfizer.com (accessed 2009 Jul 19).
9. Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burnstein AH. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. J Clin Pharmacol 2006;46:991-998 (Pubitemid 44215063)
10. Food and Drug Administration. Drug safety newsletter. www.fda.gov/ cder/dsn/2009-V2-no1/DSN-Vol2Num1.pdf (accessed 2009 Apr 7).
11. Purvis TL, Mambourg SE, Balvanz TM, Magallon HE, Pham RH. Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness. Ann Pharmacother 2009;43:862-867 Epub 21 Apr 2009. DOI 10.1345/aph.1L661
12. Food and Drug Administration. Varenicline (marketed as Chantix) information. FDA alert [2/1/2008]. www.fda.gov/Cder/drug/infopage/varenicline/ default.htm (accessed 2009 Apr 7).
13. Kuehn BM. Studies linking smoking-cessation drug with suicide risk spark concern. JAMA 2009;301:1007-1008
14. Institute for Safe Medication Practices. Strong safety signal seen for new varenicline risks. www.ismp.org/docs/vareniclinestudy.asp (accessed 2009 Apr 7).
15. Institute for Safe Medication Practices. Quarter watch: 2008 Quarter 1. www.ismp.org/quarterwatch/2008Q1.pdf (accessed 2009 Apr 7).
16. Food and Drug Administration. Information for healthcare professionals: varenicline (marketed as Chantix) and bupropion (marketed as Zyban, Wellbutrin, and generics). www.fda.gov/Drugs/DrugSafety/Postmarket DrugSafetyInformationforPatientsandProviders/DrugSafetyInformation forHeathcareProfessionals/ucm169986.htm (accessed 2009 Jul 21).